Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00557349 · ClinicalTrials.gov registry record · Phase 4
Ulcer Prevention Study in Post Gastric Bypass Patients
A Phase 4 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT00557349 is a Phase 4 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 40 participants.
The verdict
NCT00557349, a Phase 4 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery.
Interventions
- DRUG Omeprazole
- DRUG Famotidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-11 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00557349
The ClinicalTrials.gov registry entry for NCT00557349 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Omeprazole is the first listed.
NCT00557349 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00557349 about?
NCT00557349 is a clinical study titled "Ulcer Prevention Study in Post Gastric Bypass Patients". This research is to determine which medication, Zegerid (Omeprazole/Sodium Bicarbonate) or Pepcid AC (Famotidine), works best at reducing the chance that a patient will get an ulcer after gastric bypass surgery.
What is the current status of trial NCT00557349?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-11. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00557349?
The interventions under investigation include: Omeprazole (DRUG), Famotidine (DRUG).
Who is sponsoring clinical trial NCT00557349?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.